More than 100 companies
We work for across four continents
7 MAA / NDAs Submitted since 2012
with TranScrip Partners key involvement
Forecasting the Unknown
by Senior Partner, Tim Joslin... (View here to bypass YouTube)
TranScrip congratulate Vifor Pharma
as Velphoro® (PA21) is recommended for EU approval for the treatment of hyperphosphatemia in adult CKD patients on dialysis....
Adaptive Licensing: A New Way Forward
On 19th March 14, the European Medicines Agency (EMA) released notification of the pilot project on adaptive licensing, and on 6th June announced that the first two medicines for inclusion in this pilot had been selected...
Click here to read the commentary in full...